Ignite Creation Date:
2024-05-05 @ 10:10 PM
Last Modification Date:
2024-10-26 @ 10:15 AM
Study NCT ID:
NCT01048320
Status:
COMPLETED
Last Update Posted:
2012-09-25
First Post:
2010-01-11
Brief Title:
Gemcitabine and Oxaliplatin Gem-Ox Plus Glivec in Gemcitabine-refractory Pancreatic Cancer
Sponsor:
Royal Marsden NHS Foundation Trust
Organization:
Royal Marsden NHS Foundation Trust
Organization Data
Organization:
Royal Marsden NHS Foundation Trust
Class:
OTHER
Study ID:
CCR2731
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Royal Marsden NHS Foundation Trust
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Professor David Cunningham
Old Organization:
Royal Marsden NHS Foundation Trust